CoChat

EVIDENCE FOR DOPAMINE DEAMINATION BY BOTH TYPE A AND TYPE B MONOAMINE OXIDASE IN RAT BRAIN in vivo AND FOR THE DEGREE OF INHIBITION OF ENZYME NECESSARY FOR INCREASED FUNCTIONAL ACTIVITY OF DOPAMINE AND 5‐HYDROXYTRYPTAMINE

Open access
GREEN, A.R., MITCHELL, B.D., TORDOFF, ANN F.C., YOUDIM, M.B.H. · 1977 · British Journal of Pharmacology
Cited by 145

The DOI matches its Crossref record.

Abstract

1 Tranylcypromine (20 mg/kg) administration to rats totally inhibited brain monoamine oxidase (MAO) oxidation of 5‐hydroxytryptamine (5‐HT), phenylethylamine and dopamine as measured in vitro. When l‐3,4‐dihydroxyphenylalanine (l‐DOPA) (50 mg/kg) was given 30 min after the tranylcypromine, brain dopamine and noradrenaline concentrations rose markedly and the rats displayed characteristic behavioural changes and locomotor activity. 2 Clorgyline (5 mg/kg) administration inhibited 5‐HT oxidation by almost 100% but phenylethylamine by only 29% while (‐)‐deprenil (5 mg/kg) injection almost totally inhibited phenylethylamine oxidation and inhibited 5‐HT metabolism by only 31%. Administration of l‐DOPA after pretreatment with either drug did not alter brain dopamine or noradrenaline concentrations and the animals did not display any behavioural changes. 3 Administration of clorgyline plus (‐)‐deprenil (5 mg/kg of each) almost totally inhibited oxidation of both phenylethylamine and 5‐HT; there was a large rise of brain dopamine and noradrenaline concentrations and the animals displayed the behavioural changes observed when tranylcypromine and l‐DOPA had been given. 4 The effects of tranylcypromine (20 mg/kg) on brain 5‐HT, dopamine and noradrenaline concentrations up to 48 h after injection were recorded. Brain 5‐HT concentrations were considerably elevated for 18 h after injection and then fell steadily. In contrast, brain dopamine concentrations rose slightly and remained at this level for 48 h while noradrenaline levels doubled and also remained at this level for 48 hours. 5 When l‐tryptophan (50 mg/kg) was given at various times after tranylcypromine the characteristic hyperactivity syndrome appeared at 12 h but not 18 h after tranylcypromine and a further rise in brain 5‐HT was only observed at 12 hours. When l‐DOPA (50 mg/kg) was given at various times after tranylcypromine a further large rise in brain dopamine and noradrenaline occurred at 12 h but not at 18 h and all the behavioural changes were observed only at 12 hours. 6 Measurement of MAO activity at the above times after tranylcypromine showed that the half‐life of recovery of the enzyme activity with 5‐HT and dopamine as substrates was 4.5 days and 8.5 days with phenylethylamine as substrate. Inhibition of MAO oxidation of dopamine and 5‐HT was approximately 85%, 18 h after tranylcypromine injection. 7 It is concluded from both the studies with clorgyline and deprenil and the recovery of MAO activity after tranylcypromine, that dopamine is metabolized by both Type A and Type B MAO in vivo and that it is only when both forms are almost totally inhibited that there is an increase in dopamine and 5‐HT functional activity, as judged by the appearance of the hyperactivity syndromes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1476-5381.1977.tb07506.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 145

Metadata

Authors
GREEN, A. R., MITCHELL, B. D., TORDOFF, A. F. C., & YOUDIM, M. B. H.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
1977-07
Volume
60
Issue
3
Pages
343-349
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W1982916435
Cited by
145
References
0
FWCI
1.00
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: EVIDENCE FOR DOPAMINE DEAMINATION BY BOTH TYPE A AND TYPE B MONOAMINE OXIDASE IN RAT BRAIN in vivo AND FOR THE DEGREE OF INHIBITION OF ENZYME NECESSARY FOR INCREASED FUNCTIONAL ACTIVITY OF DOPAMINE AND 5‐HYDROXYTRYPTAMINE. https://app.cochat.ai/papers/10.1111/j.1476-5381.1977.tb07506.x
The paper
GREEN, A. R., MITCHELL, B. D., TORDOFF, A. F. C., & YOUDIM, M. B. H. (1977). EVIDENCE FOR DOPAMINE DEAMINATION BY BOTH TYPE A AND TYPE B MONOAMINE OXIDASE IN RAT BRAIN in vivo AND FOR THE DEGREE OF INHIBITION OF ENZYME NECESSARY FOR INCREASED FUNCTIONAL ACTIVITY OF DOPAMINE AND 5‐HYDROXYTRYPTAMINE. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.1977.tb07506.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.